Boston Scientific (BSX) Total Current Liabilities (2009 - 2026)

Boston Scientific has disclosed Total Current Liabilities across 18 years of filings, most recently posting $4.6 billion for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $4.6 billion, down 9.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 billion (down 9.63% YoY), and the FY2025 annual result was $5.4 billion, down 15.0% from the prior year.
• Total Current Liabilities came in at $4.6 billion for Q1 2026 at Boston Scientific, down from $5.4 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $6.4 billion in Q4 2024 to a low of $3.5 billion in Q3 2022.
• The 5-year median for Total Current Liabilities is $4.9 billion (2024), against an average of $4.8 billion.
• Across the five-year window, Total Current Liabilities increased 29.72% in 2024 and slipped 15.0% in 2025, its largest moves.
• Boston Scientific's Total Current Liabilities stood at $3.8 billion in 2022, then grew by 29.71% to $4.9 billion in 2023, then rose by 29.72% to $6.4 billion in 2024, then decreased by 15.0% to $5.4 billion in 2025, then fell by 15.96% to $4.6 billion in 2026.
• The last three Total Current Liabilities figures came in at $4.6 billion (Q1 2026), $5.4 billion (Q4 2025), and $5.3 billion (Q3 2025), per Business Quant data.